Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ariela Noy

Showing results (41-50 of 138) with videos related to

Pageof 14
Sort By:
British Journal of Haematology|August 24, 2005
Primary mediastinal large B-cell lymphoma: optimal therapy and prognostic factor analysis in 141 consecutive patients treated at Memorial Sloan Kettering from 1980 to 1999Paul A Hamlin, Carol S Portlock, David J Straus, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 3, 2017
Modernizing Clinical Trial Eligibility Criteria: Recommendations of the American Society of Clinical Oncology-Friends of Cancer Research HIV Working GroupThomas S Uldrick, Gwynn Ison, Michelle A Rudek, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 8, 2009
Effects of chemotherapy in AIDS-associated non-Hodgkin's lymphoma on Kaposi's sarcoma herpesvirus DNA in bloodLan Lin, Jeannette Y Lee, Lawrence D Kaplan, et al.
Tumor Microenvironment and Therapy|January 23, 2016
A Positive Prospective Trial of Antibiotic Therapy in Advanced Stage, Non-Bulky Indolent LymphomaCarol S Portlock, Paul A Hamlin, John F Gerecitano, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 6, 2016
Cancer and Fertility Program Improves Patient Satisfaction With Information ReceivedJoanne F Kelvin, Bridgette Thom, Catherine Benedict, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 1, 2014
Phase II trial of imatinib in AIDS-associated Kaposi's sarcoma: AIDS Malignancy Consortium Protocol 042Henry B Koon, Susan E Krown, Jeannette Y Lee, et al.
Cardiovascular and Interventional Radiology|November 1, 2023
Factors Affecting Diagnostic Yield of Lesional Bone Biopsy in Hematologic Malignancy PatientsTimothy M Cooke, Majid Maybody, Ahmed K Aly, et al.
Blood Neoplasia|July 24, 2024
Castleman disease patients report mild COVID-19 symptoms and mount a humoral response to SARS-CoV-2 vaccinationSaishravan Shyamsundar, Sheila K Pierson, Caoilfhionn M Connolly, et al.
Blood|April 5, 2003
Age-adjusted International Prognostic Index predicts autologous stem cell transplantation outcome for patients with relapsed or primary refractory diffuse large B-cell lymphomaPaul A Hamlin, Andrew D Zelenetz, Tarun Kewalramani, et al.
Blood Advances|December 22, 2018
Safety and efficacy of an oncolytic viral strategy using bortezomib with ICE/R in relapsed/refractory HIV-positive lymphomasErin G Reid, David Looney, Frank Maldarelli, et al.
Pageof 14

Showing results (41-50 of 138) with videos related to

Sort By:
Pageof 14
British Journal of Haematology|August 24, 2005
Primary mediastinal large B-cell lymphoma: optimal therapy and prognostic factor analysis in 141 consecutive patients treated at Memorial Sloan Kettering from 1980 to 1999Paul A Hamlin, Carol S Portlock, David J Straus, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 3, 2017
Modernizing Clinical Trial Eligibility Criteria: Recommendations of the American Society of Clinical Oncology-Friends of Cancer Research HIV Working GroupThomas S Uldrick, Gwynn Ison, Michelle A Rudek, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 8, 2009
Effects of chemotherapy in AIDS-associated non-Hodgkin's lymphoma on Kaposi's sarcoma herpesvirus DNA in bloodLan Lin, Jeannette Y Lee, Lawrence D Kaplan, et al.
Tumor Microenvironment and Therapy|January 23, 2016
A Positive Prospective Trial of Antibiotic Therapy in Advanced Stage, Non-Bulky Indolent LymphomaCarol S Portlock, Paul A Hamlin, John F Gerecitano, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 6, 2016
Cancer and Fertility Program Improves Patient Satisfaction With Information ReceivedJoanne F Kelvin, Bridgette Thom, Catherine Benedict, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 1, 2014
Phase II trial of imatinib in AIDS-associated Kaposi's sarcoma: AIDS Malignancy Consortium Protocol 042Henry B Koon, Susan E Krown, Jeannette Y Lee, et al.
Cardiovascular and Interventional Radiology|November 1, 2023
Factors Affecting Diagnostic Yield of Lesional Bone Biopsy in Hematologic Malignancy PatientsTimothy M Cooke, Majid Maybody, Ahmed K Aly, et al.
Blood Neoplasia|July 24, 2024
Castleman disease patients report mild COVID-19 symptoms and mount a humoral response to SARS-CoV-2 vaccinationSaishravan Shyamsundar, Sheila K Pierson, Caoilfhionn M Connolly, et al.
Blood|April 5, 2003
Age-adjusted International Prognostic Index predicts autologous stem cell transplantation outcome for patients with relapsed or primary refractory diffuse large B-cell lymphomaPaul A Hamlin, Andrew D Zelenetz, Tarun Kewalramani, et al.
Blood Advances|December 22, 2018
Safety and efficacy of an oncolytic viral strategy using bortezomib with ICE/R in relapsed/refractory HIV-positive lymphomasErin G Reid, David Looney, Frank Maldarelli, et al.
Pageof 14